GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wuhan Hiteck Biological Pharma Co Ltd (SZSE:300683) » Definitions » Common Stock

Wuhan Hiteck Biological Pharma Co (SZSE:300683) Common Stock : ¥130.9 Mil (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Wuhan Hiteck Biological Pharma Co Common Stock?

Wuhan Hiteck Biological Pharma Co's quarterly common stock stayed the same from Sep. 2024 (¥130.9 Mil) to Dec. 2024 (¥130.9 Mil) and stayed the same from Dec. 2024 (¥130.9 Mil) to Mar. 2025 (¥130.9 Mil).

Wuhan Hiteck Biological Pharma Co's annual common stock increased from Dec. 2022 (¥122.1 Mil) to Dec. 2023 (¥130.9 Mil) but then stayed the same from Dec. 2023 (¥130.9 Mil) to Dec. 2024 (¥130.9 Mil).


Wuhan Hiteck Biological Pharma Co Common Stock Historical Data

The historical data trend for Wuhan Hiteck Biological Pharma Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan Hiteck Biological Pharma Co Common Stock Chart

Wuhan Hiteck Biological Pharma Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 103.36 122.10 122.10 130.89 130.89

Wuhan Hiteck Biological Pharma Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 130.89 130.89 130.89 130.89 130.89

Wuhan Hiteck Biological Pharma Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Wuhan Hiteck Biological Pharma Co Business Description

Traded in Other Exchanges
N/A
Address
Hite Science and Technology Park, Wuhan Economic and Technological Development Zone, Hubei Province, Wuhan, CHN, 430056
Wuhan Hiteck Biological Pharma Co Ltd is a biopharmaceutical manufacturing enterprise in China. The company is primarily engaged in the development, production and sale of biological products. Its product portfolio comprises rat nerve growth factor freeze-dried powder injection, injection of anti-hepatitis B transfer factor freeze-dried powder injection, thrombin and other chemicals. The company also has more than 20 kinds of products such as hepatitis B treatment drug op Heparin and hemostatic agent thrombin.
Executives
Yan Jie Director
Li Sheng Qiang Executives

Wuhan Hiteck Biological Pharma Co Headlines

No Headlines